Guerbet (4G8.F) Stock Highlights

25.1 | +2.03%

2024-12-21 05:39:47

Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.

Statistics

Range Today

24.7 25.1

Volume Today 131

Range 1 Year

17.56 39.4

Volume 1 Year 2.68K

Range 3 Year

15.46 39.4

Volume 3 Year 10.64K

Range 10 Year

15.46 89.682

Volume 10 Year 27.27K

Highlights

Market Capitalization 407.09M (small)

Floating Shares 5.68M

Current Price 25.1

Price To Earnings 12.13

Price To Revenue 0.88

Price To Book 0.97

Earnings Per Share 2.46

Dividend Yield 1.66%

Dividend Per Share 0.5

Payout Ratio 20.33%

Performance

Latest +2.03%

1 Month -5.64%

3 Months -30.08%

6 Months -27.35%

1 Year +27.93%

3 Years -29.49%

5 Years -43.85%

10 Years -25.81%

Benchmarks

Market Capitalization

0 / 92

Gross Profits

0 / 85

Total Revenue

0 / 89

Total Rank

0 / 92

Free Cashflow

0 / 90

Performance 5 years

0 / 92

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.